Literature DB >> 9406347

Gene vaccination for hepatitis C.

G Inchauspé1.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9406347     DOI: 10.1007/bf00870269

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  44 in total

Review 1.  The immune functions of epidermal cells.

Authors:  G Stingl; E Tschachler; V Groh; K Wolff; C Hauser
Journal:  Immunol Ser       Date:  1989

2.  T-lymphocyte response to hepatitis C virus in different clinical courses of infection.

Authors:  P Botarelli; M R Brunetto; M A Minutello; P Calvo; D Unutmaz; A J Weiner; Q L Choo; J R Shuster; G Kuo; F Bonino
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

3.  A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.

Authors:  D Rosa; S Campagnoli; C Moretto; E Guenzi; L Cousens; M Chin; C Dong; A J Weiner; J Y Lau; Q L Choo; D Chien; P Pileri; M Houghton; S Abrignani
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

4.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.

Authors:  N Kato; H Sekiya; Y Ootsuyama; T Nakazawa; M Hijikata; S Ohkoshi; K Shimotohno
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment.

Authors:  K Koizumi; N Enomoto; M Kurosaki; T Murakami; N Izumi; F Marumo; C Sato
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

6.  Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.

Authors:  P Paterlini; F Driss; B Nalpas; E Pisi; D Franco; P Berthelot; C Bréchot
Journal:  Hepatology       Date:  1993-01       Impact factor: 17.425

7.  Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin.

Authors:  J Dubuisson; C M Rice
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1.

Authors:  H Sekiya; N Kato; Y Ootsuyama; T Nakazawa; K Yamauchi; K Shimotohno
Journal:  Int J Cancer       Date:  1994-06-01       Impact factor: 7.396

9.  An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.

Authors:  M Shirai; H Okada; M Nishioka; T Akatsuka; C Wychowski; R Houghten; C D Pendleton; S M Feinstone; J A Berzofsky
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo.

Authors:  Y Higashi; S Kakumu; K Yoshioka; T Wakita; M Mizokami; K Ohba; Y Ito; T Ishikawa; M Takayanagi; Y Nagai
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.